Insufficient knowledge of Korean gastroenterologists regarding the vaccination of patients with inflammatory bowel disease

Gut and Liver

Volumn 8, Issue 3, 2014, Pages 242-247

  Jung, Yoon Suk ^a   Park, Jung Ho ^a   Kim, Hong Joo ^a   Cho, Yong Kyun ^a   Sohn, Chong Il ^a   Jeon, Woo Kyu ^a   Kim, Byung Ik ^a   Park, Dong Il ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Immunization; Immunosuppression; Inflammatory bowel disease; Vaccine

Indexed keywords

BIOLOGICAL FACTOR; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOMODULATING AGENT; INFLUENZA VACCINE; LIVE VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; AWARENESS; FEMALE; GASTROENTEROLOGIST; HUMAN; INFECTION; INFECTION RISK; INFLAMMATORY BOWEL DISEASE; KNOWLEDGE; KOREA; MALE; PRACTICE GUIDELINE; VACCINATION; ANAMNESIS; ATTITUDE TO HEALTH; CLINICAL COMPETENCE; COMPLICATION; GASTROENTEROLOGY; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; PHYSIOLOGY; QUESTIONNAIRE; SOUTH KOREA; STANDARDS;

CLINICAL COMPETENCE; FEMALE; GASTROENTEROLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; INFLAMMATORY BOWEL DISEASES; MALE; MEDICAL HISTORY TAKING; QUESTIONNAIRES; REPUBLIC OF KOREA; VACCINATION;

EID: 84901198169     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2014.8.3.242     Document Type: Article

References (27)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434. (Pubitemid 47123518)
2. Moum B. Medical treatment: does it influence the natural course of inflammatory bowel disease? Eur J Intern Med 2000;11:197-203.
3. Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010;59:1200-1206.
4. Domm S, Cinatl J, Mrowietz U. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol 2008;159:1217-1228.
5. Keene JK, Lowe DK, Grosfeld JL, Fitzgerald JF, Gonzales-Crussi F. Disseminated varicella complicating ulcerative colitis. JAMA 1978;239:45-46. (Pubitemid 8270178)
6. Deutsch DE, Olson AD, Kraker S, Dickinson CJ. Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine. J Pediatr Gastroenterol Nutr 1995;20:351-353.
7. Lemyze M, Tavernier JY, Chevalon B, Lamblin C. Severe varicella zoster pneumonia during the course of treatment with azathioprine for Crohn's disease. Rev Mal Respir 2003;20(5 Pt 1):773-776. (Pubitemid 37429426)
8. Leung VS, Nguyen MT, Bush TM. Disseminated primary varicella after initiation of infliximab for Crohn's disease. Am J Gastroenterol 2004;99:2503-2504. (Pubitemid 40039388)
9. Vergara M, Brullet E, Campo R, Calvet X, Blanch L. Fulminant infection caused by varicella herpes zoster in patient with Crohn disease undergoing treatment with azathioprine. Gastroenterol Hepatol 2001;24:47. (Pubitemid 32113098)
10. Esteve M, Saro C, González-Huix F, Suarez F, Forné M, Viver JM. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 2004;53:1363-1365. (Pubitemid 39120128)
11. Ritz MA, Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. Inflamm Bowel Dis 2001;7:327.
12. Foster KJ, Devitt N, Gallagher PJ, Abbott RM. Overwhelming pneumococcal septicaemia in a patient with ulcerative colitis and splenic atrophy. Gut 1982;23:630-632. (Pubitemid 12081118)
13. Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006;101:1834-1840. (Pubitemid 44166594)
14. Loras C, Saro C, Gonzalez-Huix F, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol 2009;104:57-63.
15. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis 2011;17:2536-2540.
16. Yeung JH, Goodman KJ, Fedorak RN. Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients. Inflamm Bowel Dis 2012;18:34-40.
17. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008;14:542-549. (Pubitemid 351571835)
18. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 2010;105:1231-1238.
19. Nichol KL, Mac Donald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996;11:673-677. (Pubitemid 26425484)
20. Kwon OS, Park YS, Choi JH, et al. A case of ulcerative colitis relapsed by influenza vaccination. Korean J Gastroenterol 2007;49:327-330.
21. Fields SW, Baiocco PJ, Korelitz BI. Influenza vaccinations: should they really be encouraged for IBD patients being treated with immunosuppressives? Inflamm Bowel Dis 2009;15:649-651.
22. Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis 2009;15:1410-1416.
23. Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis 2009;15:1399-1409.
24. Dotan I, Werner L, Vigodman S, et al. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis 2012;18:261-268.
25. Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:851-856. (Pubitemid 47031059)
26. Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009;104:444-453.
27. Gelinck LB, van der Bijl AE, Beyer WE, et al. The effect of antitumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008;67:713-716. (Pubitemid 351571939)